Congress rejects trump’s plan to cut medical research funding

Cover Story Capitol Hill Developments Republican-led Congress Rejects President Trump's Proposal to Reduce Funding for Medical Research The Senate advances a bill increasing NIH funding by $400 million, offering some positive news for cancer research funding. Cancer Policy Updates In Brief Clinical Trials Summary Drugs and Targets National Cancer Institute (NCI) Clinical Trials for August 2025 Last month, the NCI approved several new clinical research studies. Trending News Right-wing activist Laura Loomer criticizes FDA official Vinay Prasad FY25 funding paylines drop to historic lows at the 4th percentile amid anticipated budget reductions for FY26 under Trump Biotech entrepreneur George Tidmarsh joins FDA as Director of the Center for Drug Evaluation and Research (CDER) His appointment reportedly influenced by connections to Makary and Bhattacharya Could Multi-Cancer Detection (MCD) Tests Transform Screening? NCI begins enrollment in the Vanguard feasibility trial to explore this Shane Jacobson appointed CEO of the American Cancer Society and ACS CAN Dr. Robert Winn raises concerns: "If Medicaid faces significant cuts or is eliminated, where will patients receive care?"